We report the case of a 73-year-old man who developed metastatic small-cell lung cancer to the bony external auditory canal (EAC). The patient had only recently been diagnosed with his primary carcinoma. The metastasis presented as a bulky, fleshy, bleeding mass in the right EAC. Biopsy of the metastasis revealed that its histologic characteristics were identical to those of the primary. This case is of interest because this was a unique type of metastasis to the EAC. Although there are reports in the literature of lung cancer and even small-cell cancer metastasizing to the temporal bone, we could find no previously published report of a small-cell lung carcinoma metastasizing to the EAC.
Introduction
Metastases to the external auditory canal (EAC) are uncommon. We report a case of a small-cell lung cancer that spread to the EAC. To the best of our knowledge, this is the first report of its kind.
Case report
A 73-year-old white man presented to the emergency department with a bleeding mass of the right EAC. Ten days earlier, he had been hospitalized at our institution for investigation of a suspicious pulmonary finding on computed tomography (CT). A subsequent bronchial biopsy and histologic examination revealed a massive infiltration of the lung by small-cell cancer with foci of necrosis. The tumor cells showed diffuse and strong positivity for thyroid transcription factor 1 (TTF-1), as well as for synaptophysin, chromogranin, and neuronspecific enolase.
At the emergency department, the patient said he had noticed the EAC mass a few days earlier when it began to bleed. The mass was painless. The patient had a history of heavy smoking, non-insulin-dependent diabetes mellitus, hypertension, and cholelithiasis, but no remarkable otologic history.
Physical examination of the right ear revealed that a large, fleshy mass had filled the entire circumference of the EAC and protruded slightly from within the external meatus. A biopsy was obtained from the superoanterior aspect of the bony right external auditory canal. Histologic examination identified the EAC mass as a metastatic small-cell carcinoma of lung origin (figure 1). The metastasis had the same morphologic and immunohistochemical profile as the bronchial mass. Temporal bone CT found no local bone destruction (figure 2), although there were some foci in the jawbones of uncertain radiologic significance.
In view of the extensiveness of the patient's disease at presentation-a large primary tumor, a distant metastasis to the EAC, and suspicious lytic lesions in the maxilla-surgery was not an option, so the patient began chemotherapy. He died 6 months later. 
Discussion
Because carcinoma metastatic to the temporal bone is uncommon, it is often not recognized. Also, these metastases may be missed because they are either asymptomatic or overshadowed by other metastases late in the course of a particular patient's disease.
Single cases of temporal bone metastasis have been reported as spreading from the breast, lung, prostate, vagina, hypopharynx, colon, and other sites. [1] [2] [3] [4] [5] In a review of 165 cases of temporal bone metastases, Cumberworth et al found that the most common sites of the primary tumors were the breast (29% of cases), lung (11%), prostate (8%), and kidney (6%), while the origin of 8% was unknown. 6 The fact that many metastases to the temporal bone are microscopic and asymptomatic may mean that their incidence is underestimated.
Because the presentation of a primary or metastatic carcinoma of the EAC often mimics chronic suppurative ear disease, the diagnosis of EAC cancer is often not confirmed until 6 months or more after the onset of symptoms. Furthermore, a metastatic workup does not routinely include temporal bone imaging.
The interest in this case goes beyond its being the first of its kind because it raises the question of how malignancies spread to and within the temporal bone. Several mechanisms have been proposed to explain the occurrence of temporal bone metastasis from distant primary sites:
• Hematogenous spread can lead to seeding of the marrow spaces in the petrous bone. 7 Indeed, metastases to the temporal bone most often involve the petrous apex.
• A possible pathway for spread could occur when tumor cells gain access to the cerebrospinal fluid, cross the subarachnoid space, enter the internal auditory canal, and invade the temporal bone. 3 • A two-step theory suggests that tumor cells first metastasize to the neck and from there they spread to the skull. Malignancies of the abdomen and chest are known to ascend to the head and neck via the thoracic duct on the left side and the lymphatic duct on the right side. Malignancies from distant sites have been known to appear in the left supraclavicular nodes. Backflow from this site can then lead to other implants in the head and neck, including the temporal bone. 5, 8, 9 The presenting symptoms of primary cancer arising in the EAC and temporal bone have been well described. An analysis of 442 patients from different series found that the two most common symptoms were otorrhea (61%) and otalgia (51%). 7 While some authors have emphasized the significance of bloody otorrhea in diagnosing cancer, this finding is not pathognomonic. 7 Once the histologic diagnosis of cancer of the EAC has been made, high-resolution CT is unsurpassed for assessing the integrity of the osseous structures of the temporal bone.
Although the primary lesion in this case was diagnosed a short time before the identification of the EAC metastasis, in a different scenario the metastasis might have been the initial presentation of lung carcinoma. Therefore, when one encounters a lesion of the EAC, the differential diagnosis and subsequent investigation should include consideration of a primary lung tumor, including a small-cell lung cancer. 
